Meta-analysis results PCa For cohort studies, the risk of PCa in patients with IBD were of borderline significant increase (SIR: 1.09; 95% CI: 0.95–1.22; I 2 =61.2%; Figure 2 ) when compared with the background population, as was the risk of subgroup of UC (SIR: 1.13; 95% CI: 0.93–1.33; I 2 =73.5%; Figure 2 ) and CD (SIR: 1.05; 95% CI: 0.90–1.21; I 2 =15.1%; Figure 2 ).
← all excerpts
Does inflammatory bowel disease increase the risk of lower urinary tract tumors: a meta-analysis.
1
—
—